ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 204 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $9,774,791 | -31.6% | 931,820 | -14.3% | 0.00% | -33.3% |
Q3 2023 | $14,284,047 | +2.4% | 1,087,066 | -1.8% | 0.00% | 0.0% |
Q2 2023 | $13,950,392 | -6.6% | 1,107,174 | -3.2% | 0.00% | 0.0% |
Q1 2023 | $14,931,837 | -29.3% | 1,144,202 | -4.5% | 0.00% | -40.0% |
Q4 2022 | $21,127,162 | +5.0% | 1,197,685 | -9.3% | 0.01% | 0.0% |
Q3 2022 | $20,121,000 | +6.9% | 1,321,136 | +4.1% | 0.01% | +25.0% |
Q2 2022 | $18,829,000 | -36.8% | 1,269,673 | -4.1% | 0.00% | -33.3% |
Q1 2022 | $29,803,000 | +25.8% | 1,323,414 | +3.1% | 0.01% | +50.0% |
Q4 2021 | $23,695,000 | +29.5% | 1,284,204 | -6.2% | 0.00% | 0.0% |
Q3 2021 | $18,297,000 | -33.9% | 1,368,470 | -8.5% | 0.00% | -20.0% |
Q2 2021 | $27,691,000 | +15.9% | 1,496,022 | -6.0% | 0.01% | 0.0% |
Q1 2021 | $23,898,000 | -3.0% | 1,591,588 | -6.7% | 0.01% | 0.0% |
Q4 2020 | $24,632,000 | +67.7% | 1,705,870 | -5.5% | 0.01% | +25.0% |
Q3 2020 | $14,688,000 | +17.4% | 1,804,389 | -2.3% | 0.00% | +33.3% |
Q2 2020 | $12,507,000 | -0.5% | 1,847,626 | +3.5% | 0.00% | -25.0% |
Q1 2020 | $12,564,000 | -36.6% | 1,784,519 | -11.6% | 0.00% | -20.0% |
Q4 2019 | $19,823,000 | -10.7% | 2,019,649 | -0.1% | 0.01% | -16.7% |
Q3 2019 | $22,204,000 | -14.8% | 2,022,276 | -9.7% | 0.01% | -14.3% |
Q2 2019 | $26,053,000 | +25.5% | 2,239,995 | +2.9% | 0.01% | +16.7% |
Q1 2019 | $20,758,000 | -6.6% | 2,175,836 | -5.6% | 0.01% | -14.3% |
Q4 2018 | $22,215,000 | -33.0% | 2,304,552 | -1.0% | 0.01% | -22.2% |
Q3 2018 | $33,160,000 | +14.7% | 2,326,933 | -3.4% | 0.01% | +12.5% |
Q2 2018 | $28,909,000 | -10.1% | 2,409,113 | -7.5% | 0.01% | -11.1% |
Q1 2018 | $32,171,000 | -16.3% | 2,604,903 | -1.4% | 0.01% | -10.0% |
Q4 2017 | $38,457,000 | -24.9% | 2,643,176 | -26.5% | 0.01% | -28.6% |
Q3 2017 | $51,184,000 | -10.8% | 3,596,920 | -20.0% | 0.01% | -12.5% |
Q2 2017 | $57,359,000 | +7.9% | 4,495,169 | +7.2% | 0.02% | +6.7% |
Q1 2017 | $53,165,000 | +39.1% | 4,192,875 | +12.0% | 0.02% | +36.4% |
Q4 2016 | $38,215,000 | -34.6% | 3,743,009 | -15.7% | 0.01% | -35.3% |
Q3 2016 | $58,446,000 | -8.1% | 4,437,689 | -11.4% | 0.02% | -10.5% |
Q2 2016 | $63,593,000 | +68.1% | 5,007,096 | +74.8% | 0.02% | +72.7% |
Q1 2016 | $37,838,000 | +16.2% | 2,864,403 | +35.2% | 0.01% | +10.0% |
Q4 2015 | $32,574,000 | +15.9% | 2,118,021 | -6.6% | 0.01% | +11.1% |
Q3 2015 | $28,114,000 | +1.0% | 2,267,236 | +11.5% | 0.01% | +12.5% |
Q2 2015 | $27,825,000 | +18.8% | 2,034,013 | +3.9% | 0.01% | +33.3% |
Q1 2015 | $23,421,000 | +0.2% | 1,958,278 | +7.0% | 0.01% | 0.0% |
Q4 2014 | $23,377,000 | -8.2% | 1,830,651 | -3.6% | 0.01% | -14.3% |
Q3 2014 | $25,477,000 | -57.3% | 1,899,230 | -48.9% | 0.01% | -12.5% |
Q2 2014 | $59,708,000 | -24.5% | 3,720,040 | -15.2% | 0.01% | -63.6% |
Q1 2014 | $79,101,000 | +17.7% | 4,387,133 | +0.9% | 0.02% | +15.8% |
Q4 2013 | $67,191,000 | -50.8% | 4,346,098 | -52.7% | 0.02% | -9.5% |
Q3 2013 | $136,680,000 | +135.0% | 9,191,640 | +104.5% | 0.02% | +16.7% |
Q2 2013 | $58,164,000 | – | 4,494,958 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |